Review of the Rationale for Strategic Shareholdings and Impairment Risk
First written in FY2021. 1 of 2 entries say "Restated". Latest entry: FY2024.
49 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「The company holds the shares in question only when there is a reasonable basis for doing so. It quantitatively evaluates whether returns, including dividends and transaction status, are commensurate with risk. If the shares have no quantitative holding significance, it evaluates whether there are qualitative reasons supporting the reasonableness of continued ownership and discusses whether to continue holding them.」
Regarding cross-shareholdings, the company reconfirmed its evaluation of the quantitative and qualitative significance of holding the shares and its discussions on continued ownership. - FY2021First statedAnnual report
「The company holds the shares in question only when there is a reasonable basis for doing so. It quantitatively evaluates whether returns, including dividends and transaction status, are commensurate with risk. If the shares have no quantitative holding significance, it evaluates whether there are qualitative reasons supporting the reasonableness of continued ownership and discusses whether to continue holding them. The Board of Directors also reviews the risk of impairment due to factors such as a decline in the share price on each occasion.」
Regarding cross-shareholdings, the company disclosed for the first time its policy of quantitatively evaluating returns and risks, confirming qualitative reasons for holding the shares, and having the Board of Directors review impairment risk.